Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03857659 · ClinicalTrials.gov registry record · NA
Serial Third Trimester Abdominal Circumference and Amniotic Fluid Measurements Versus Routine Care
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- NA
- Development phase
- 113
- Enrollment target
NCT03857659 is a NA study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 113 participants.
The verdict
NCT03857659, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- NA
- Development phase
- 113 participants
- Enrollment target
Study Summary
The purpose of this study us to compare the rate of prenatal identification of abnormal fetal growth or amniotic fluid between clinical evaluation of uterine size by symphysis fundal height (SFH) measurements versus point-of-care ultrasound (POC-US) evaluation of abdominal circumference (AC) and maximum vertical pocket (MVP).
Interventions
- DIAGNOSTIC_TEST Point-of-care ultrasound (POC-US)
- DIAGNOSTIC_TEST Routine antenatal care
- DIAGNOSTIC_TEST Formal ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2019-04-05 |
| Est. Completion | 2020-05-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03857659
The ClinicalTrials.gov registry entry for NCT03857659 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Point-of-care ultrasound (POC-US) is the first listed.
NCT03857659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03857659 about?
NCT03857659 is a clinical study titled "Serial Third Trimester Abdominal Circumference and Amniotic Fluid Measurements Versus Routine Care". The purpose of this study us to compare the rate of prenatal identification of abnormal fetal growth or amniotic fluid between clinical evaluation of uterine size by symphysis fundal height (SFH) measurements versus point-of-care ultrasound (POC-US) evaluation of abdominal circumference (AC) and max...
What is the current status of trial NCT03857659?
This trial is currently terminated. It is a NA study. The enrollment target is 113 participants. The study started on 2019-04-05. Estimated completion is 2020-05-20.
What interventions are being tested in trial NCT03857659?
The interventions under investigation include: Point-of-care ultrasound (POC-US) (DIAGNOSTIC_TEST), Routine antenatal care (DIAGNOSTIC_TEST), Formal ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03857659?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.